In the wake of the increase in Current Liabilities in the third quarter 2023, Quick Ratio fell to 1.3 a new company low.

Within Biotechnology & Pharmaceuticals industry 142 other companies have achieved higher Quick Ratio than Seagen Inc in third quarter 2023. While Quick Ratio total ranking in the third quarter 2023 has deteriorated compared to the prior quarter from 835 to 1683.

Explain Quick Ratio?
How much Cash & cash equivalents SGEN�s has?
What are SGEN�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/SGEN/financial-strength

https://api.csimarket.com/api/v1/companies/SGEN/fundamentals

https://api.csimarket.com/api/v1/companies/SGEN/fundamentals?mode=as_of&as_of=YYYY-MM-DD

Programmatic access for models, analytics, and integration workflows.

Explore the Financial Data API

Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery

Connect Your AI Assistant

How to Connect Your AI Assistant to CSIMarket MCP MCP Server

Access this full dataset via API

Free sample Full docs All endpoints

SGEN Quick Ratio	(Sep 30 2023) Q3	(Jun 30 2023) Q2	(Mar 31 2023) Q1	(Dec 31 2022) Q4	(Sep 30 2022) Q3
Y / Y Current Liabilities Change	31.5 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent Change	-29.86 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio MRQ	1.3	Subscribe	Subscribe	Subscribe	Subscribe
SGEN's Total Ranking	# 1683	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities Change	25.14 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent Change	-4.27 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick Ratio third quarter 2023 Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 143
Healthcare Sector	# 706
Overall Market	# 1683

Quick Ratio Statistics
High	Average	Low
6.59	3.41	1.3
(Dec 31 2020)		(Sep 30 2023)

Financial Statements
Seagen Inc 's Current Liabilities	$ 955 Millions	Visit SGEN's Balance sheet
Seagen Inc 's Cash & cash equivalent	$ 1,237 Millions	Visit SGEN's Balance sheet
Source of SGEN's Sales		Visit SGEN's Sales by Geography

Cumulative Seagen Inc 's Quick Ratio

SGEN's Quick Ratio for the trailling 12 Months

SGEN Quick Ratio	(Sep 30 2023) 12 Months	(Jun 30 2023) 12 Months	(Mar 31 2023) 12 Months	(Dec 31 2022) 12 Months	(Sep 30 2022) 12 Months
Y / Y Current Liabilities TTM Growth	33.46 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent TTM Growth	-25.51 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio TTM	1.77	Subscribe	Subscribe	Subscribe	Subscribe
Total Ranking TTM	# 2148	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities TTM Growth	7.57 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent TTM Growth	-8.39 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick ratio ranking by company, industry and sector >> Back to SGEN Financial Strength Comparisons >> Go to Compare SGEN Quick Ratio to its Competitors

On the trailing twelve months basis Due to growth in Current Liabilities in the Q3 2023 to $954.72 millions, cumulative Quick Ratio decreased to 1.77 above the SGEN average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Biotechnology & Pharmaceuticals industry 167 other companies have achieved higher Quick Ratio than Seagen Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2023 from 3792 to 4137.

Explain Quick Ratio?
How much Cash & cash equivalents SGEN�s has?
What are SGEN�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Biotechnology & Pharmaceuticals Industry	# 168
Healthcare Sector	# 1084
Within the Market	#

trailing twelve months Quick Ratio Statistics
High	Average	Low
2	0.85	0.4
(Jun 30 2016)		(Jun 30 2019)

Companies with similar Quick Ratio in the quarter ending Sep 30 2023, within Biotechnology & Pharmaceuticals Industry	Quick Ratio	Sep 30 2023 MRQ Cash & cash equivalent	Sep 30 2023 MRQ Current Liabilities
Enzo Biochem Inc	3.38	$ 69.207 Millions	$ 20.480 Millions
Omega Therapeutics Inc	3.33	$ 89.300 Millions	$ 26.816 Millions
Miromatrix Medical inc	3.23	$ 16.062 Millions	$ 4.966 Millions
Fennec Pharmaceuticals Inc	3.19	$ 12.399 Millions	$ 3.892 Millions
Aligos Therapeutics Inc	3.13	$ 70.429 Millions	$ 22.468 Millions
Poseida Therapeutics Inc	3.10	$ 238.837 Millions	$ 76.973 Millions
Relay Therapeutics Inc	2.98	$ 151.328 Millions	$ 50.748 Millions
Vericel Corporation	2.93	$ 105.343 Millions	$ 35.946 Millions
Exelixis Inc	2.93	$ 1,103.387 Millions	$ 376.816 Millions
Inmune Bio Inc	2.91	$ 41.813 Millions	$ 14.356 Millions
Armata Pharmaceuticals Inc	2.84	$ 23.958 Millions	$ 8.441 Millions
Gamida Cell Ltd	2.82	$ 116.653 Millions	$ 41.325 Millions
Freeline Therapeutics Holdings Plc	2.80	$ 29.452 Millions	$ 10.521 Millions
Lineage Cell Therapeutics Inc	2.60	$ 41.332 Millions	$ 15.881 Millions
Arcellx Inc	2.54	$ 439.716 Millions	$ 173.149 Millions
Precision Biosciences Inc	2.41	$ 122.231 Millions	$ 50.617 Millions
Halozyme Therapeutics Inc	2.38	$ 274.227 Millions	$ 115.185 Millions
Regenxbio Inc	2.37	$ 301.887 Millions	$ 127.346 Millions
Exscientia Plc	2.29	$ 185.389 Millions	$ 81.047 Millions
Windtree Therapeutics Inc	2.25	$ 7.365 Millions	$ 3.270 Millions
Adaptimmune Therapeutics Plc	2.15	$ 161.728 Millions	$ 75.146 Millions
Immunitybio inc	2.10	$ 189.796 Millions	$ 90.324 Millions
Amgen Inc	2.05	$ 34,741.000 Millions	$ 16,954.000 Millions
Genfit S a	2.02	$ 87.124 Millions	$ 43.098 Millions
C4 Therapeutics Inc	2.01	$ 60.971 Millions	$ 30.271 Millions
Adma Biologics Inc	1.82	$ 74.157 Millions	$ 40.715 Millions
Innate Pharma Sa	1.78	$ 79.078 Millions	$ 44.393 Millions
Vaxart Inc	1.76	$ 19.799 Millions	$ 11.268 Millions
Biomx Inc	1.76	$ 22.450 Millions	$ 12.784 Millions
Moderna Inc	1.73	$ 7,573.000 Millions	$ 4,385.000 Millions

Date modified: 2026-10-07T00:41:51+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.